Karim Abdelhamid
Lausanne, VD 1011, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Stereotactic radiotherapy of inoperable localized lung cancers
Journal: Revue medicale suisse
Published: May 18, 2026
Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges.
Journal: The Lancet. Respiratory medicine
Published: May 09, 2026
Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related Myocarditis.
Journal: JACC. CardioOncology
Published: September 04, 2025
Adverse effects of new therapeutic approaches in thoracic oncology
Journal: Revue medicale suisse
Published: May 15, 2025
Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 09, 2024
Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 10, 2024
Management of bone metastasis in non-small cell lung cancer
Journal: Revue medicale suisse
Published: May 17, 2024
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma.
Journal: Nature communications
Published: August 03, 2023
Targeted therapies and non-small cell carcinomas : novelties
Journal: Revue medicale suisse
Published: May 18, 2022
Last Updated: 09/26/2026